Source: Health Canada shortage reports · Updated Nov 4, 2026
Some Nepafenac products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 15, 2026.
An anti-inflammatory eye drop used to reduce pain and swelling after eye surgery.
Products affected
1 / 2
In shortage since
Jul 20, 2026
Est. full return
Nov 15, 2026
Reports on file
9
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
DIN 02308983 · ended Apr 10, 2018 · Delay in shipping of the drug.
What's happening
Nepafenac is currently affected by an active shortage report filed with Health Canada by NOVARTIS PHARMACEUTICALS CANADA INC.
The reported cause is: shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Nepafenac is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).
Recent changes
Nov 4, 2026
Estimated end date pushed back : Oct 15, 2026 → Nov 15, 2026
Oct 27, 2026
Status changed
Sep 29, 2026
New report filed
Jul 20, 2026
Estimated end date pushed back : Oct 8, 2026 → Oct 15, 2026
Common questions
What is Nepafenac used for?
An anti-inflammatory eye drop used to reduce pain and swelling after eye surgery.
When will Nepafenac be back in stock in Canada?
The latest manufacturer estimate is Nov 15, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Nepafenac in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.